An article about Toshihiro Ishikiriyama, our president, and Kenji Osafune, our Chief Scientific Advisor , was published in serial column: Series EMBARK of K-iCAP.
Aiming to innovate the treatment of chronic kidney disease (CKD) with iPS cell therapy
Aiming to innovate the treatment of chronic kidney disease (CKD) with iPS cell therapy
